1st Quarter - Report

KNIGHT CAPITOL CONSULTANTS for BRAEBURN PHARMACEUTICALS, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the treatment of opioid addiction, including: S. 524, the Comprehensive Addiction Recovery Act (CARA) and amendments thereto; S. 1893, Mental Health Awareness and Improvement Act of 2015; H.R. 3691, Improving Treatment for Pregnant and Postpartum Women Act; H.R. 3680, Co-Prescribing to Reduce Overdoses Act of 2015; H.R. 2536/S.1455, the Recovery Enhancement for Addiction Treatment Act; H.R. 2805; the Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015; and H.R. 2872, the Opioid Addiction Treatment Modernization Act.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Sen. Orrin G. Hatch

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); SENATE

Bills named: S. 1893 (114th), H.R. 2536 (114th), H.R. 3680 (114th), S. 524 (114th), S. 1455 (114th), H.R. 2805 (114th), H.R. 3691 (114th), H.R. 2872 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.